# US 2001/0012622 A1 · Method for isolating inhibitors of protease activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0012622 A1
- Document ID: US20010012622A1
- Status: Published application
- Kind: A1
- Application number: 09/799,141
- Filed: 2001-03-05
- Published: 2001-08-09
- Earliest claimed: 1998-03-27
- Assignees: Long Island Jewish Medical Center
- Inventors: Srinivasa K. Rao; Leslie Kushner; Mahesh Mathrubutham; Jon R. Cohen
- Web page: https://patentgrep.com/patent/US20010012622A1

## CPC

- C12Q 1/34: involving hydrolase
- C12Q 1/37: involving peptidase or proteinase
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention provides an assay for detecting and quantifying protease that is sensitive, rapid, and capable of screening numerous samples of small volume. Also provided by the present invention is a method for diagnosing disorders associated with connective tissue destruction in a subject by detecting and quantifying a particular protease in a biological sample. Further provided by the present invention is a method of detecting inhibitors of the activity of a protease by detecting primary amines that are exposed by the enzymatic degradation of a protease substrate.

## Claims

### Claim 1

A method for detecting the presence of an inhibitor of a protease in a biological sample comprising the steps of:
(a) reacting the biological sample with a succinylated protease substrate to obtain a reaction mixture,
(b) reacting said reaction mixture with a known amount of protease to obtain a reaction comprising primary amines,
(c) adding to said reaction mixture an amount of TNBSA sufficient to bind to said primary amines present in said mixture and to obtain a color reaction,
(d) detecting the presence of an inhibitor in said reaction mixture by comparing the color intensity of said reaction mixture with a control reaction mixture.

### Claim 2 (depends on 1)

The method of claim 1, wherein the substrate is selected from the group consisting of elastin, casein and gelatin.

### Claim 3 (depends on 1)

The method of claim 1, wherein the biological sample is selected from the group consisting of whole blood, plasma, serum, synovial fluid, urine, saliva, sputum, and mucous secretion.
